Since the adoption of a new model for assessing the severity of liver disease, women are more likely to be added to the ...

In the international SUMMIT trial, adults with heart failure preserved ejection fraction (HFpEF) and obesity taking tirzepatide for up to 3 years had a reduced combined risk of worsening heart failure ...